Humanities
Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Challenging diagnosis of a rare disease: hypophosphatemic osteomalacia – case report and literature review
  • Home
  • /
  • Challenging diagnosis of a rare disease: hypophosphatemic osteomalacia – case report and literature review
  1. Home /
  2. Archives /
  3. Vol. 72 (2024) /
  4. Health Sciences

Challenging diagnosis of a rare disease: hypophosphatemic osteomalacia – case report and literature review

Authors

  • Agnieszka Nowak Medical University of Lodz https://orcid.org/0009-0008-9298-9536
  • Alicja Partyka Poznan University of Medical Sciences https://orcid.org/0000-0002-3929-4654
  • Magdalena Pach Medical University of Lodz https://orcid.org/0009-0000-3608-9471
  • Justyna Dobrzańska Medical University of Lodz https://orcid.org/0000-0001-9797-3375
  • Mariola Dziedzic Medical University of Lodz https://orcid.org/0009-0004-8518-1572
  • Aneta Michalczewska University Clinical Centre of the Medical University of Warsaw https://orcid.org/0009-0003-1353-2575
  • Agnieszka Fugas Jan Kochanowski University of Kielce https://orcid.org/0009-0008-5973-817X
  • Natalia Wierzejska Medical University of Warsaw https://orcid.org/0009-0006-5373-400X
  • Zuzanna Chmielowiec LUX MED Sp. z o.o. https://orcid.org/0009-0005-3974-9793
  • Karolina Smykiewicz Medical University of Silesia Faculty of Medical Sciences in Zabrze https://orcid.org/0009-0003-9510-600X

DOI:

https://doi.org/10.12775/JEHS.2024.72.51116

Keywords

osteomalacia, tumor-induced osteomalacia, hypophosphatemia, fibroblast growth factor-23, vitamin D, calcium-phosphate management

Abstract

Hypophosphatemic osteomalacia is a rare condition caused by different causes, all resulting in disturbances of calcium-phosphate management. One of the most common causes among adults is tumor-induced osteomalacia, which is characterized by increased secretion of fibroblast growth factor-23. Its symptoms are vague, tests necessary for diagnosis are not commonly used by clinicians and some of them are only available in highly specialized centers. Due to these reasons, patients often are misdiagnosed for more common conditions and are left without proper treatment for many years. We present a case of a patient suffering from multiple fractures, diffuse bone pain, and muscle weakness, who was previously misdiagnosed for osteoporosis, primary and secondary hyperparathyroidism. We discuss the pathophysiology of tumor-induced osteomalacia, diagnostic path, differential diagnosis, available forms of treatment and possible complications.

References

Ito N, Hidaka N, Kato H. The pathophysiology of hypophosphatemia. Best Pract Res Clin Endocrinol Metab. 2024;38(2):101851. doi:10.1016/J.BEEM.2023.101851

Rendina D, Abate V, Cacace G, et al. Tumor-induced Osteomalacia: A Systematic Review and Individual Patient’s Data Analysis. J Clin Endocrinol Metab. 2022;107(8):e3428-e3436. doi:10.1210/clinem/dgac253

Portales-Castillo I, Rieg T, Khalid SB, Nigwekar SU, Neyra JA. Physiopathology of Phosphate Disorders. Advances in Kidney Disease and Health. 2023;30(2):177-188. doi:10.1053/J.AKDH.2022.12.011

Yin Z, Du J, Yu F, Xia W. Tumor-induced osteomalacia. Osteoporos Sarcopenia. 2018;4(4):119-127. doi:10.1016/J.AFOS.2018.12.001

Kim KJ, Song JE, Kim JH, et al. Elevated morbidity and mortality in patients with chronic idiopathic hypophosphatemia: a nationwide cohort study. Front Endocrinol (Lausanne). 2023;14. doi:10.3389/fendo.2023.1229750

Aligail K, Dave JA, Ross IL. Tumor-induced osteomalacia: a case report. J Med Case Rep. 2022;16(1). doi:10.1186/s13256-021-03220-7

Jadhav SS, Shah R, Patil V. Tumor-induced osteomalacia: An overview. Best Pract Res Clin Endocrinol Metab. 2024;38(2):101834. doi:10.1016/J.BEEM.2023.101834

Bosman A, Palermo A, Vanderhulst J, et al. Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases. Calcif Tissue Int. 2022;111(4):367-379. doi:10.1007/s00223-022-01005-8

Cundy T, Que L, Hassan IM, Hughes L. Bisphosphonate‐Induced Deterioration of Osteomalacia in Undiagnosed Adult Fanconi Syndrome. JBMR Plus. 2020;4(8). doi:10.1002/jbm4.10374

Lee GJ, Marks J. Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond? Pediatric Nephrology. 2015;30(3):363-371. doi:10.1007/s00467-014-2759-x

Sabbagh Y, Giral H, Caldas Y, Levi M, Schiavi SC. Intestinal Phosphate Transport. Adv Chronic Kidney Dis. 2011;18(2):85-90. doi:10.1053/j.ackd.2010.11.004

Yee J, Rosenbaum D, Jacobs JW, Sprague SM. Small Intestinal Phosphate Absorption: Novel Therapeutic Implications. Am J Nephrol. 2021;52(7):522-530. doi:10.1159/000518110

Fukumoto S. The role of bone in phosphate metabolism. Mol Cell Endocrinol. 2009;310(1-2):63-70. doi:10.1016/j.mce.2008.08.031

Thomas L, Dominguez Rieg JA, Rieg T. Npt2a as a target for treating hyperphosphatemia. Biochem Soc Trans. 2022;50(1):439-446. doi:10.1042/BST20211005

Bergwitz C, Jüppner H. Regulation of Phosphate Homeostasis by PTH, Vitamin D, and FGF23. Annu Rev Med. 2010;61(1):91-104. doi:10.1146/annurev.med.051308.111339

Kolek OI, Hines ER, Jones MD, et al. 1α,25-Dihydroxyvitamin D 3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2005;289(6):G1036-G1042. doi:10.1152/ajpgi.00243.2005

Goltzman D, Mannstadt M, Marcocci C. Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis. In: ; 2018:1-13. doi:10.1159/000486060

Aljuraibah F, Bacchetta J, Brandi ML, et al. An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia. Journal of Bone and Mineral Research. 2022;37(1):12-20. doi:10.1002/jbmr.4486

Shimada T, Hasegawa H, Yamazaki Y, et al. FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis. Journal of Bone and Mineral Research. 2004;19(3):429-435. doi:10.1359/JBMR.0301264

Saponaro F, Saba A, Zucchi R. An Update on Vitamin D Metabolism. Int J Mol Sci. 2020;21(18):6573. doi:10.3390/ijms21186573

Jan de Beur SM, Minisola S, Xia W bo, et al. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia. J Intern Med. 2023;293(3):309-328. doi:10.1111/joim.13593

Hori M, Shimizu Y, Fukumoto S. Minireview: Fibroblast Growth Factor 23 in Phosphate Homeostasis and Bone Metabolism. Endocrinology. 2011;152(1):4-10. doi:10.1210/en.2010-0800

Fukumoto S, Hasegawa Y. Special Issue: “X-Linked Hypophosphatemia.” Endocrines. 2023;4(4):720-721. doi:10.3390/endocrines4040052

Gupta A, Dwivedi A, Patel P, Gupta S. Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis: Case report and literature review. Indian Journal of Radiology and Imaging. 2015;25(1):63-66. doi:10.4103/0971-3026.150155

Obo T, Koriyama N, Tokito A, Ogiso K, Nishio Y. Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23: A case report. J Med Case Rep. 2020;14(1). doi:10.1186/s13256-020-02381-1

Kancherla K, Constantin H, Kanawati A, Graham E. Iron-induced Hypophosphatemic Osteomalacia-An Atypical Case of Bilateral Femoral Stress Fractures. J Am Acad Orthop Surg Glob Res Rev. 2023;7(5). doi:10.5435/JAAOSGlobal-D-22-00155

Samões B, Silva B, Martins A, et al. Hypophosphatemic osteomalacia induced by intravenous iron therapy: a case report. Joint Bone Spine. 2023;90(5):105586. doi:10.1016/J.JBSPIN.2023.105586

Vilaca T, Velmurugan N, Smith C, Abrahamsen B, Eastell R. Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports. Journal of Bone and Mineral Research. 2022;37(6):1188-1199. doi:10.1002/jbmr.4558

He H, Zhang YJ. Multiple-level spinal fractures due to adefovir-induced Fanconi syndrome and hypophosphatemic osteomalacia: A case report. Asian J Surg. 2023;46(4):1712-1713. doi:10.1016/J.ASJSUR.2022.09.140

Palermo A, Strollo R, Papalia R, et al. Severe hypophosphatemic osteomalacia secondary to fanconi syndrome due to adefovir: A case report. Endocrine Practice. 2014;20(12):e246-e249. doi:10.4158/EP14251.CR

Wang M, Cao X, Cao B. Hypophosphatemic vitamin D-resistant osteomalacia: A case report. Exp Ther Med. 2013;6(3):791-795. doi:10.3892/etm.2013.1209

Hawke K, Croft A, Lazarus S. Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia. Case Rep Gastroenterol. Published online 2024:81-89. doi:10.1159/000536136

Li X, Cheng D, Sun Z, Jiao Q, Wang C, Fan Y. An Unusual Case of Bone Pain, Hypophosphatemia, and a Gastric Mass: A Quiz. American Journal of Kidney Diseases. 2024;83(3):A16-A20. doi:10.1053/j.ajkd.2023.09.013

Ikegawa K, Hasegawa Y. Presentation and Diagnosis of Pediatric X-Linked Hypophosphatemia. Endocrines. 2023;4(1):128-137. doi:10.3390/endocrines4010012

Fukumoto S. FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment. J Mol Endocrinol. 2021;66(2):R57-R65. doi:10.1530/JME-20-0089

Jiang Y, Li X, Huo L, et al. Consensus on clinical management of tumor-induced osteomalacia. Chin Med J (Engl). 2021;134(11):1264-1266. doi:10.1097/CM9.0000000000001448

Takeuchi Y, Suzuki H, Ogura S, et al. Venous Sampling for Fibroblast Growth Factor-23 Confirms Preoperative Diagnosis of Tumor-Induced Osteomalacia. J Clin Endocrinol Metab. 2004;89(8):3979-3982. doi:10.1210/jc.2004-0406

Minisola S, Fukumoto S, Xia W, et al. Tumor-induced Osteomalacia: A Comprehensive Review. Endocr Rev. 2023;44(2):323-353. doi:10.1210/endrev/bnac026

Paramba F, Silas M, Masoodi N, Benjamin S, Palaki JA. Hypophosphatemic Osteomalacia in a Young Adult. Cureus. Published online March 4, 2021. doi:10.7759/cureus.13697

Brunelli SM, Goldfarb S. Hypophosphatemia: Clinical consequences and management. Journal of the American Society of Nephrology. 2007;18(7):1999-2003. doi:10.1681/ASN.2007020143

Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician’s guide to X-linked hypophosphatemia. Journal of Bone and Mineral Research. 2011;26(7):1381-1388. doi:10.1002/jbmr.340

Spaleniak S, Kade G, Kidziński R, Mazurek A, Lubas A, Niemczyk S. Tumor-induced hypophosphatemic osteomalacia as a rare cause of bone pain. Pol Arch Intern Med. 2018;128(3):189-191. doi:10.20452/pamw.4234

Downloads

  • PDF

Published

2024-05-26

How to Cite

1.
NOWAK, Agnieszka, PARTYKA, Alicja, PACH, Magdalena, DOBRZAŃSKA, Justyna, DZIEDZIC, Mariola, MICHALCZEWSKA, Aneta, FUGAS, Agnieszka, WIERZEJSKA, Natalia, CHMIELOWIEC, Zuzanna and SMYKIEWICZ, Karolina. Challenging diagnosis of a rare disease: hypophosphatemic osteomalacia – case report and literature review. Journal of Education, Health and Sport. Online. 26 May 2024. Vol. 72, p. 51116. [Accessed 16 November 2025]. DOI 10.12775/JEHS.2024.72.51116.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 72 (2024)

Section

Health Sciences

License

Copyright (c) 2024 Agnieszka Nowak, Alicja Partyka, Magdalena Pach, Justyna Dobrzańska, Mariola Dziedzic, Aneta Michalczewska, Agnieszka Fugas, Natalia Wierzejska, Zuzanna Chmielowiec, Karolina Smykiewicz

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 523
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

osteomalacia, tumor-induced osteomalacia, hypophosphatemia, fibroblast growth factor-23, vitamin D, calcium-phosphate management
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop